TGA power to be ex­panded - Sk­er­ritt

Pharmacy Daily - - FRONT PAGE -

THE gov­ern­ment’s de­ci­sion to elim­i­nate pre-ap­proval for ad­ver­tis­ing of ther­a­peu­tic goods will mean the Ther­a­peu­tic Goods Ad­min­is­tra­tion re­quires “strong and timely com­pli­ance pow­ers,” ac­cord­ing to John Sk­er­ritt, head of the Health Prod­ucts Reg­u­la­tion Group which over­sees the TGA.

Sk­er­ritt told yes­ter­day’s ASMI con­fer­ence in Sydney the changes will see a new mech­a­nism for man­ag­ing com­plaints, while the TGA’s in­ves­ti­ga­tion and en­force­ment pro­grams will also be broad­ened as a re­sult.

He said the TGA was cur­rently de­vel­op­ing op­tions pa­pers on ar­eas such as S3 ad­ver­tis­ing and the new com­plaints process, with stake­holder work­shops to be held in the com­ing months.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.